Daewoong Pharmaceutical Co. Ltd.

This early-stage trial tests a microneedle patch called DWRX5003 that delivers semaglutide, a drug used for obesity and type 2 diabetes. The study involves 72 healthy adults to check safety and how well the drug enters the body compared to standard injections. It is not yet testi…

This study tests whether a new version of the drug olaparib (DWZ2501) works as well as the current version (DWC202510) in women with advanced BRCA-mutated ovarian cancer. About 40 participants will take both versions at different times to compare drug levels and safety. The goal …

This observational study will follow 12,000 Korean adults with stage 1 hypertension who are newly prescribed OLMETEC or OLMETEC Plus. The main goal is to see how well the medication controls blood pressure over 24 hours, especially at night. Participants will have their blood pre…

This early-stage study tests a new drug called DWP212525 in 84 healthy adults aged 19 to 55. The main goal is to check safety and how the drug moves through the body. It is the first step in developing a possible treatment for autoimmune diseases.

This early-stage trial is testing the safety and how the body handles three experimental drugs—DWJ1622, DWC202313, and DWC202314—in 40 healthy adults. Participants take a single dose of each drug under fasting conditions. The study aims to measure drug levels in the blood and che…

This early-phase study is testing three experimental drugs (DWJ1622, DWC202313, and DWC202314) in 36 healthy adults. The goal is to see how the body absorbs and processes these drugs and to check for any safety issues. Participants will take the drugs by mouth after eating. This …